Skip to content

13F-HR filed by Arlington Capital Management, Inc.

Arlington Capital Management, Inc. filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-17, with 31 holding rows worth $118,167,000.

Accession
0001085146-15-000622
Filed
2015-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 31 entries on the cover page, a total value of $118,167,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $118,167,000 with VALUE read as thousands by filing date, 13F file number 028-16665. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ISHARES TR464287556ISHARES BIOTECH49,836$15,118,000thousands by filing date
ISHARES TR464287192US TRSPRTION77,367$12,694,000thousands by filing date
ISHARES TR464288828US HLTHCR PR ETF102,039$12,078,000thousands by filing date
ISHARES INDIA 50 ETF464289529UIT EXCHANGE TRADED387,192$11,577,000thousands by filing date
DBX ETF TR XTRACK HRVST CSI233051879XTRACK HRVST CSI208,635$7,763,000thousands by filing date
SOUTHWESTAIRLSCO844741108STOK179,105$7,580,000thousands by filing date
L BRANDS INC501797104COM85,782$7,424,000thousands by filing date
ULTA BEAUTY INC COM90384S303Stock51,257$6,553,000thousands by filing date
ISHARES TR464287184CHINA LG-CAP ETF146,741$6,107,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM25,544$3,035,000thousands by filing date
CELGENE CORP151020104COM25,828$2,889,000thousands by filing date
XPO INC COM983793100Stock67,970$2,779,000thousands by filing date
Amgen Inc.031162100COM16,937$2,698,000thousands by filing date
MEDIVATION INC58501N101COM26,177$2,607,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM26,439$2,390,000thousands by filing date
JP MORGAN CHASE & CO46625H365EXCHANGE TRADED46,469$2,135,000thousands by filing date
MEDICAL PROPERTIES TRUST INC COM58463J304REIT106,752$1,471,000thousands by filing date
CENTURYLINK INC156700106COM34,405$1,362,000thousands by filing date
NEW YORK COMMUNITY BANCORP649445103COM82,998$1,328,000thousands by filing date
HATTERAS FINL CORP41902R103COM71,095$1,310,000thousands by filing date
ISHARES TR464288539MRTG PLS CAP IDX111,535$1,306,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock3,086$1,266,000thousands by filing date
HANCOCK JOHN PFD INCOME FD I41013X106COM48,325$983,000thousands by filing date
BANK OF AMER CORP0605056827.25%CNV PFD L817$949,000thousands by filing date
ISHARES TR464288281JPMORGAN USD EMG7,392$811,000thousands by filing date
Philip Morris International Inc.718172109COM5,867$478,000thousands by filing date
AT&T Inc00206R102COM13,753$462,000thousands by filing date
SEASPAN CORPY75638109SHS19,796$357,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR3,953$278,000thousands by filing date
EXELON CORP COM30161N101Stock5,915$219,000thousands by filing date
WESTERN ASSET EMERGING MARKETS95766A101COM10,155$160,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-15-000622this filing2015-02-17acceptance time not in the bulk data set